Changes in the abundance and properties of blood lipoproteins are generally considered major causes for varied pathological conditions and diseases. Using novel chromatic biomimetic vesicle and cell assays, we present here for the first time evidence for significant changes in lipoproteins' interactions with artificial membranes. Specifically, we demonstrate significant differences in membrane binding between lipoproteins (both low-density lipoprotein [LDL] and high-density lipoprotein [HDL]) harvested from diabetic patients vs. healthy controls as well as between oxidized and native lipoproteins. The chromatic assays, complemented by biophysical techniques and electron microscopy, point to significant reduction of surface membrane binding of the lipoproteins as a consequence of diabetes or oxidation. Overall, our results indicate that the substantial modulation of membrane interactions revealed by the chromatic assays may be used as a new and potentially powerful marker for screening and prediction of diseases associated with oxidative stress.
Introduction
Lipoprotein particles perform the physiologic task of transporting dietary and endogenously produced lipids [1] . Chylomicrons transport dietary lipids, while very low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) function to transport endogenous lipids. VLDL are triglyceride-rich particles, whereas LDL and HDL function as cholesterol transporters. In humans, the majority of serum cholesterol is carried by LDL particles. Increased LDL-cholesterol levels and/or low levels of HDL are associated with increased risk of cardiovascular disease [2] .
Lipoprotein abnormalities are pathological consequences of type 2 diabetes. In particular, dyslipidemia is a common feature in patients with the disease and is believed to be responsible for the high risk of complications associated with atherosclerosis in such patients [3] . Compositional changes in lipoprotein components may also account for the increased atherogenicity found in diabetes. It was previously shown that the ratio of esterified-to-free cholesterol was increased in LDL particles from diabetic patients, thus rendering the LDL to increased oxidizability [4] . Many lines of evidence implicate a major role to the formation of oxidized LDL (Ox-LDL) in atherosclerosis [5, 6] , and there is now consensus that atherosclerosis represents a state of heightened oxidative stress [7] . There is considerable evidence demonstrating that oxidative stress plays a central role in the pathology of diabetes [8, 9] , and many studies have evidenced that Ox-LDL is increased in diabetes [4] . Another characteristic lipid abnormality in diabetic patients is low HDL levels in plasma. Furthermore, the HDL composition in diabetes is altered with higher triglycerides. As a result, the cardioprotective effects of HDL (reverse cholesterol transport and protection of LDL against oxidation) are significantly reduced in diabetic patients [4] .
This study employed newly developed biomimetic chromatic assays for evaluating the extent of membrane interactions of lipoproteins. The biomimetic assays are based upon polydiacetylene (PDA), a lipid-like polymer which exhibits unique colorimetric and fluorescence properties [10, 11] . Specifically, it has been shown that in mixed lipid/PDA vesicles [12] or in living cells decorated with PDA patches fused to the plasma membrane [13] , the polymer undergoes dramatic blue-red and fluorescence transformations induced by membrane events occurring within the lipid bilayer domains [14] . The chromatic changes of PDA correspond to structural transitions of Biochimica et Biophysica Acta 1788 (2009 [2436] [2437] [2438] [2439] [2440] [2441] [2442] [2443] Abbreviations: DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DMPE, 1,2-dimyristoyl-sn-glycero-3-phospho-ethanolamine; DMPG, 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]; DPH, diphenylhexatriene; FRET, fluorescence resonance energy transfer; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PDA, polydiacetylene; NBD-PE, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)1,2 dihexadecanoylsn-glycero-3 phospho-ethanolamine, triethylammonium salt; Rhodamine-DHPE, Rhodamine Red™-X 1,2-dihexadecanoyl-sn-glycero-3-phospho-ethanolamine, triethylammonium salt ⁎ Corresponding authors. [12, 15] . In this study we questioned whether application of lipid/PDA assays uncovers dramatic modulation of membrane binding of native lipoproteins compared to lipoproteins harvested from diabetic patients or lipoproteins oxidized in vitro.
Here we show that membrane interactions with LDL and HDL, probed by recently developed biomimetic polymer-based vesicle and cell assays, are significantly affected both in diabetic patients, as well as in oxidized vs. native lipoproteins.
Materials and methods

Materials
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) was purchased from Avanti (Alabaster, AL), and 1,2-dimyristoyl-snglycero-3-[phospho-rac-(1-glycerol)] (DMPG), 1,2-dimyristoyl-snglycero-3-phospho-ethanolamine (DMPE) and sodium dithionite were purchased from Sigma. The diacetylenic monomer 10,12-tricosadiynoic acid (TRCDA) was purchased from Alfa Aesar (Karlsruhe, Germany). The powder was washed in chloroform and purified through a nylon 0.45 μm filter (Whatman) before use.
Tris(hydroxymethyl)aminomethane (TRIZMA base buffer, C 4 H 11 NO 3 ) was purchased from Sigma. The fluorescent dyes N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)1,2-dihexadecanoyl-sn-glycero-3 phospho-ethanolamine, triethylammonium salt (NBD-PE) and Rhodamine Red™-X 1,2-dihexadecanoyl-sn-glycero-3-phospho-ethanolamine, triethylammonium salt (Rhodamine-DHPE) were purchased from Molecular Probes (Leiden, Netherlands).
Human subjects
Ten male patients with type 2 diabetes mellitus, at the age 59 ± 2 years, with serum glucose levels of 199 ± 33 mg/dL, hemoglobin A1c levels of 7.5-11.3% and body mass index (BMI) of 30 ± 3 kg/m 2 , were included in the study All patients were non-smokers.
Ten healthy volunteers, with plasma cholesterol levels lower than 200 mg/dL, were recruited from the Faculty of Medicine students and staff. These volunteers were under no drug treatment, non-smokers and with no metabolic disorders and were included in the study as controls. Blood was collected from all subjects after 12 h of fast. The study protocol was approved by the Rambam Helsinki Committee (No. 3073). Plasma lipid profiles of the patients were as follows: LDLcholesterol, −83 ± 7 mg/dL; HDL-cholesterol-43 ± 3 mg/dL; triglycerides-183 ± 23 mg/dL.
Lipoprotein isolation
HDL and LDL were isolated from human plasma samples by discontinuous density gradient ultracentrifugation [16] and dialyzed against saline-Na EDTA (1 mmol/L). HDL and LDL protein concentration was determined with the Folin phenol reagent [17] .
Lipoprotein oxidation
For oxidation, HDL and LDL harvested from healthy subjects were diluted in phosphate-buffered saline (PBS) to 1 mg of protein/mL and dialyzed overnight against PBS at 4°C to remove the EDTA. Oxidation of the lipoproteins was carried out at 37°C under air in a shaking water bath. HDL and LDL (1 mg protein/mL) were incubated for 4 h at 37°C with 35 μmol/L of freshly prepared CuSO 4 . Oxidation was terminated by refrigeration at 4°C. The oxidation extent of Ox-HDL and Ox-LDL was determined by the TBARS assay [18] .
Vesicle preparation
Vesicles containing the diacetylene monomer 10,12-tricosadiynoic acid (TRCDA) and the lipid components (DMPC/TRCDA-2:3 mole ratio, DMPE/DMPG/TRCDA-1:1:3) were dissolved in chloroform/ ethanol (1:1) and dried together in vacuo to constant weight, followed by addition of deionized water to a final concentration of 1 mM and subsequently probe sonicated at 40 W at 70°C for 3 min. The vesicle solution was subsequently cooled at room temperature and kept at 4°C overnight. The solution was then irradiated at 254 nm for 30 s, resulting in intense blue color appearance due to polymerization of the diacetylene units.
Vesicles containing only phospholipids (DMPC, DMPE/DMPG-1:1 mole ratio) were sonicated at 26 W for 10 min at room temperature and then kept at 4°C overnight prior to experiments.
Chromatic cell experiments
Macrophages J-774 were grown in DMEM medium supplemented with 5% (v/v) heat-inactivated fetal calf serum, 4 mM L-glutamine, 5 μ/ mL penicillin and 50 μg/mL streptomycin in a humidified 5% CO 2 atmosphere at 37°C.
The cells were seeded on 24-well plates to 90% confluence the day before the experiment and subsequently washed with HEPES buffer. The diacetylene/DMPE/DMPG vesicles (final lipid concentration of 0.4 mM) were added to the cells in HEPES buffer in 1.5 mL volume and incubated for 30 min with gentle shaking. Following incubation, the labeled cells were irradiated for 30 s at 254 nm using a hand-held UV lamp (UVC-16, Ultra Lum Inc., Claremont, Canada) or a BLX-254 UVCrosslinker (Marne La Vallee, France) to achieve polymerization of PDA. Irradiation resulted in an intense blue appearance of the cell monolayer. The unbound vesicles were subsequently removed through careful washing several times, and fresh HEPES buffer was added before conducting measurements. All experimental steps were carried out at 25°C.
Fluorescence spectroscopy
Fluorescence was measured on a Fluscan Ascent using a 96-well microplate (grainer), using excitation of 544 nm and emission of 620 nm using LP filters with normal slits. Using this excitation/ emission pair assured that the background fluorescence of the vesicle solutions before addition of the lipoproteins was negligible.
Samples for fluorescence measurements were prepared by adding 10 μL lipoprotein solutions to 30 μL of lipid/PDA vesicles followed by addition of 30 μL 50 mM Tris base buffer (pH 8.0). The samples were incubated for 30 min at 26°C prior to measurements. The concentrations of parent solutions were 80 ± 20 mg/dL (LDL) and 130 ± 30 mg/dL (HDL); no experimentally significant differences in chromatic responses were observed within these concentration ranges.
Fluorescent chromatic responses were calculated according to the formula:
in which Em I is the value obtained for the vesicle solution after incubation with lipoproteins, and Em red is the maximal fluorescence value obtained for the red-phase vesicles (treated with Triton). The chromatic results reported represent statistical distribution of multiple measurements of lipoproteins from different patients and using different vesicle batches.
Fluorescence quenching
NBD-PE was added to DMPE/DMPG vesicles at a molar ratio of 1:100 (fluorescent dye : phospholipid) and dried together in vacuo prior to sonication (see vesicle preparation). Samples were prepared by adding 10 μL of the lipoproteins to 30 μL of the vesicles containing the fluorescent probe and 30 μL of 50 mM Tris base buffer (pH 8.0). The final concentrations obtained were 11 mg/dL (LDL) and 17 mg/dL (HDL). Measurements were carried out after diluting the sample with distilled water to a total volume of 1 mL and incubating at 26°C for 30 min.. The quenching reaction was initiated by adding sodium dithionite from a stock solution of 0.6 M, prepared in 50 mM Tris base buffer (pH 11) to a final concentration of 1 mM. The decrease in fluorescence emission was recorded for 7 min at room temperature using 469 nm excitation and 530 nm emission on an Edinburgh Co. FL920 spectrofluorometer (Edinburgh, Scotland, UK). The fluorescence decay curves were calculated as a percentage of the initial fluorescence measured before the addition of dithionite.
Fluorescence resonance energy transfer (FRET)
N-(7-Nitro-2,1,3-benzoxadiazol-4-yl)-phosphatidylethanolamine (N-NBD-PE, fluorescence donor) and N-(lissamine rhodamine B sulfonyl) phosphatidylethanolamine (N-Rh-PE, fluorescence acceptor) were added to DMPE/DMPG vesicles at a molar ratio of 1:1:100 (NBD-PE:Rh-PE:phospholipids) and dried together in vacuo prior to sonication (see vesicle preparation). Samples were prepared by adding 30 μL of the lipoproteins to 10 μL of the vesicles containing the fluorescent probes and 30 μL of 50 mM Tris base buffer (pH 8.0). Final concentrations were 35 mg/dL (LDL) and 50 mg/dL (HDL). Fluorescence measurements were carried out after diluting the samples with distilled water to a total volume of 1 mL and incubating at 26°C for 30 min. Fluorescence emission spectra were acquired (excitation 469 nm) in the range of 500-650 nm on an FL920 spectrofluorometer (Edinburgh, UK), using a 1-cm optical path cell. To measure maximum dispersion of the fluorescent dyes (100% reduction of FRET), 30 μL of Triton X-100 (t-octylphenoxy polyethoxyethanol, Sigma) was added to the vesicles [19] . The percentage decrease of FRET was determined by the equation:
where Rf is the ratio between the emissions at 530 and 590 nm, respectively, in vesicle solutions incubated with the lipoprotein; Ri is the ratio for the solution containing only vesicles; and Rt is the ratio measured in vesicle solutions treated with Triton.
Confocal fluorescence microscopy
Cell samples for microscopy analysis were prepared according to the procedure described above (chromatic cell experiments), except that the cells were seeded on 35-mm glass-bottom MatTek dishes. Fluorescence images of the PDA-labeled cells were acquired on a laser-scanning confocal microscope Axiovert-100 M (Zeiss, Germany) with a Plan-Neofluar 63 × /1.2 oil objective. Excitation wavelength 488 nm was produced by an argon laser. Emitted light was passed through an LP 505 nm filter.
Cryogenic transmission electron microscopy (cryo-TEM)
Samples for the cryo-TEM microscopy were prepared in the same way as for the FRET experiment, above. Four microliters of the sample to be measured was deposited on perforated polymer films supported on a 300-mesh carbon-coated EM grid (copper, Ted Pella-lacey substrate). Ultrathin films (b300 nm) were formed by removing most of the solution by blotting. The process was carried out in a vitrification system in which the temperature and relative humidity were controlled, using a Vitrobot (FEI) automatic system. Cryo-TEM images were recorded on an FEI Tecnai 12 G2 TWIN TEM equipped with a Gatan 626 cold stage operating at 120 kV.
Results
Chromatic vesicle assay
Lipoproteins are known to bind to membrane-embedded receptors, such as the LDL receptor [20] . To evaluate non-specific binding of lipoproteins to lipid bilayers, we applied the biomimetic lipid/PDA vesicle assay (Fig. 1) . This simple assay was designed to probe the extent of membrane binding of tested molecules through induction of both visible color as well as fluorescence transformations within chromatic lipid/polymer vesicles [12] . Fig. 1A presents a scanned image of a multi-well plate containing dimyristoylphosphatydilcholine (DMPC)/PDA vesicles (mole ratio 2:3) treated with different HDL samples (similar results, qualitatively, we recorded in case of LDL, data not shown).
The colorimetric (blue-red) transitions of PDA-based systems go hand in hand with induction of fluorescence [21] . variations in chromatic responses apparent in Fig. 2 are due to distinct affinities of the lipoproteins examined to membrane bilayers. Fig. 2 highlights several important trends. First, differences in chromatic response induced by the lipoproteins were apparent between the two vesicle lipid compositions employed (DMPC compared to DMPE/DMPG). This result underscores the dependence of lipoprotein binding to the bilayer upon the molecular properties of the lipids, such as the size of the head group or its electrostatic charge. Fig. 2 also points to generally higher fluorescence signals induced by LDL ( Fig. 2A ) compared to HDL (Fig. 2B) , which can most likely be traced to the lower surface density and bigger size of the LDL particles [22] .
Comparable to the results presented in Fig. 1 , the bar diagram in Fig. 2 also demonstrates that experimentally significant differences in lipid binding occurred between lipoproteins extracted from healthy controls vs. diabetic patients and between native and oxidized lipoproteins. For example, LDL isolated from sera of healthy controls induced a %FCR of approximately 70% when added to DMPE/DMPG/ PDA vesicles (Fig. 2Ai, dark bars) ; the fluorescence chromatic response was reduced to less than 40% for LDL harvested from diabetic patients (Fig. 2Aii, dark bars) and around 30% in case of oxidized LDL (Fig. 2Aiii, dark bars) .
Higher chromatic signals from lipoproteins extracted from healthy controls were observed also in case of HDL (Fig. 2B) , particularly when HDL was incubated with DMPE/DMPG/PDA vesicles (Fig. 2B , dark bars), but also in case of DMPC/PDA vesicles (Fig. 2B, white bars) . Beside the differences between vesicles interactions of healthy vs. diabetic-extracted lipoproteins, Fig. 2 points to a higher chromatic response induced by native lipoproteins vs. lipoproteins oxidized in vitro. This trend was universal-occurring in both vesicle compositions and for both HDL and LDL. A non-parametric version of one-way ANOVA test was performed (Kruskal-Wallis) on all data sets to confirm the statistical significance of the observed variations in Fig. 2 The p-values obtained were all under the threshold of p = 0.05 (except in the case of LDL added to DMPC/PDA vesicles where p = 0.09). Indeed, this was the only result in which no apparent difference was observed between the lipoproteins extracted from healthy and diabetic patients, respectively). Thus, the ANOVA test results indicate that the differences in the chromatic data presented in Fig. 2 are experimentally significant.
Polymer-labeled cell assay
To gain insight into lipoprotein binding to actual cellular plasma membranes (rather than biomimetic chromatic vesicles, summarized in Figs. 1 and 2) , we analyzed lipoprotein/membrane interactions using a recently developed PDA-labeled live cell assay [13, 15] . The PDA-labeled cells platform illuminates binding to the plasma membrane of living cells by amphiphilic or hydrophobic molecules through monitoring the fluorescent emission of PDA patches fused to the cell surface [13] . Fig. 3A ) exhibit scattered low-fluorescence regions since the PDA patches fused to the cell membrane were in the initial polymerized phase [13] . However, significantly enhanced fluorescent domains localized within the cell surfaces appeared following incubation of the PDA-labeled cells with HDL isolated from healthy controls (Fig. 3B) . The pronounced fluorescence is due to the structurally transformed PDA, most likely affected by perturbations to the plasma membrane induced by binding of the HDL particles.
In contrast to the marked fluorescence induced by membrane interactions with native HDL particles (Fig. 3B) , incubation of the PDA-labeled cells with HDL extracted from diabetic patients yielded much reduced fluorescence emission (Fig. 3C ). This result is ascribed to lesser membrane binding of the diabetes-affected HDL particles and is consistent with the chromatic vesicle results presented in Figs. 1 and 2 . Similarly insignificant fluorescence induction of membrane-embedded PDA was observed when oxidized HDL particles were incubated with the cells (Fig. 3D) . Furthermore, similar differences of fluorescence induction were also observed in case of LDL particles (data not shown), confirming the observation that significant modulation of membrane interactions occur upon using lipoproteins harvested from diabetic patients compared to healthy controls.
Biophysical and microscopy analyses
The results presented in Figs. 1-3 using the chromatic vesicles and cell assays both point to significant membrane disruption by lipoproteins and particularly differences between membrane binding of lipoproteins harvested from diabetic patients and following lipoprotein oxidation, as compared to healthy controls. In order to corroborate the results and interpretation of the chromatic assay analysis, we carried out experiments utilizing complementary biophysical techniques (Figs. 4 and 5) . Fig. 4 depicts the results of a fluorescence resonance energy transfer (FRET) experiment employing DMPE/DMPG vesicles that also incorporated the fluorophores N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-phosphatidylethanolamine (N-NBD-PE, fluorescence donor) and N-(lissamine rhodamine B sulfonyl) phosphatidylethanolamine (NRh-PE, fluorescence acceptor) [23] . FRET experiments have been widely used to monitor membrane fusion and bilayer interactions [23] . Initially, efficient fluorescence energy transfer occurs between the donor and acceptor within the vesicles containing the two fluorophores (which are in close proximity). However, when bilayer perturbation and/or fusion of the fluorophore-containing vesicles with other (un-labeled) particles takes place, the extent of fluorescence energy transfer is reduced [23] . The bar diagram in Fig. 4 demonstrates a significant reduction of energy transfer following incubation of the NBD-PE/Rh-PE/DMPE/ DMPG with different lipoproteins. In general, FRET disruption appeared more pronounced when the vesicles were incubated with LDL particles (Fig. 4A ) compared to HDL (Fig. 4B ) (higher percentage corresponds to greater bilayer disruption, see Materials and methods). This observation echoes the lower chromatic signals recorded after incubating the lipid/PDA vesicles with HDL compared to LDL (Fig. 2) and most likely reflects the lesser propensity of the more compact HDL to bind and insert into lipid bilayers. Fig. 4 further illustrates that disease-affected or oxidized lipoproteins exhibited lesser effects upon the recorded FRET values compared to the lipoproteins harvested from healthy controls. For example, LDL harvested from serum of healthy controls resulted in almost 40% FRET decrease (Fig. 4Ai) , while the corresponding values following incubation of the NBD-PE/Rh-PE/DMPE/DMPG vesicles with diabetic LDL (Fig. 4Aii) and with oxidized LDL particles (Fig. 4Aiii) were around 25% and 35%, respectively. Similar modulation of the FRET results was observed for HDL (Fig. 4B) . Overall, the FRET results summarized in Fig. 4 are fully consistent with the chromatic data in Figs. 1-3 , which pointed to significantly lower membrane binding of LDL and HDL isolated from diabetic patients or oxidized. A non-parametric version of one-way ANOVA test was performed (Kruskal-Wallis) on all data sets, producing p-values that were lower than 0.05, confirming the statistical significance of the differences in the FRET values recorded in Fig. 4 . Fig. 5 depicts the results of fluorescence quenching experiments utilizing NBD-PE/DMPE/DMPG vesicles. The experiments summarized in Fig. 5 record the modulation of the fluorescence quenching of NBD by sodium dithionite added to the vesicle solution. Quenching of the NBD-PE dye, which is embedded within the lipid bilayers, is generally affected by binding of membrane-active species, such as the lipoproteins in this study [24] .
Similar to the chromatic data (Figs. 1-3 ) and FRET analysis (Fig. 4) , the quenching data in Fig. 5 demonstrate that significant differences occurred between the bilayer binding profiles of lipoproteins harvested from healthy controls, on the one hand, and either lipoproteins harvested from diabetic patients or oxidized lipoproteins, on the other hand. This discrepancy was apparent both in case of LDL (Fig. 5A) , as well as HDL (Fig. 5B) , although some differences were observed between the two lipoprotein classes.
Specifically, in the case of LDL (Fig. 5A) , the slower quenching rate recorded after pre-incubation of the NBD-PE/DMPE/DMPG vesicles with particles from the healthy controls is indicative of tight binding of the lipoproteins onto the vesicle surface, which consequently partly shields the NBD dye from the soluble dithionite quencher [24] . This interpretation is consistent with the chromatic vesicle data; previous studies have correlated pronounced chromatic responses to tight binding to lipid bilayer surfaces [25] . Fig. 5A further shows that LDL from diabetic patients or oxidized LDL both yielded faster fluorescence quenching in comparison with the native LDL, signifying lesser binding at the vesicle surface. Indeed, in case of LDL, the quenching rates observed following pre-incubation with abnormal LDL (Fig. 5A , curves iii and iv) appear close to the rate recorded for control vesicles (Fig. 5A, curve i) .
Quenching experiments utilizing HDL particles (Fig. 5B ) similarly displayed significantly faster rates of lipoproteins harvested from diabetic patients or oxidized compared to normal particles. In the case of HDL, however, the quenching curves of the particles harvested from diabetic patients (Fig. 5A, curve iii) or oxidized particles (Fig. 5B , curve iv) were in fact lower than the control vesicles for which no lipoproteins were added (Fig. 5B, curve i) . This effect is ascribed to insertion of the HDL particles (which are smaller and more condensed than the LDL particles) into the lipid bilayers, exposing the NBD dye to the soluble dithionite [24] and thus facilitating more rapid quenching than the control vesicles.
To examine whether distinct membrane interactions of the lipoproteins can be also discerned through microscopy, we examined DMPC vesicles incubated with different LDL specimens using cryogenic-transmission electron microscopy (cryo-TEM; Fig. 6 ). While cryo-TEM has been previously used for analysis of LDL microstructures [26, 27] , Fig. 6 examines the effect of the LDL particles upon the phospholipid vesicles. The electron micrographs in Fig. 6 demonstrate that LDL particles exert significant structural effects upon DMPC unilamellar vesicles, and moreover there exist pronounced differences between the structural effects upon the vesicles by native LDL compared to diabetic or oxidized LDL. Fig. 6B shows that incubation of the DMPC vesicles with native LDL resulted in swelling of the vesicles, combined with apparent encapsulation of smaller vesicles. The modified multilamellar vesicular structures are most likely induced through binding of the LDL particles to the lipid vesicles (the individual LDL particles can be discerned as the darker particulates at the grid interface; Fig. 6B , bottom image). Significantly different vesicular structures, however, were observed following incubation of DMPC with LDL harvested from diabetic patients (Fig. 6C ) or following incubation with oxidized LDL (Fig. 6D) . The cryo-TEM images in Figs. 6C and D reveal slightly distorted unilamellar vesicles punctuated on one side with darker aggregates. We speculate that the opaque assemblies attached to the lipid vesicles depicted in Fig. 6C correspond to aggregates of the small LDL particles; lower abundance of LDL particles was indeed observed in the cryo-TEM analysis of the diabetic and oxidized LDL samples compared to the native LDL.
Cryo-TEM experiments examining the interactions of HDL particles and DMPC vesicles similarly revealed intriguing differences between normal or abnormal HDL (Fig. 7) . While HDL obtained from healthy individuals yielded somewhat swollen and distorted DMPC vesicles ( Fig. 7B ; the individual non-reacted HDL particulates can be discerned at the grid interface), HDL isolated from diabetic patients gave rise to noticeably smaller DMPC vesicles encapsulating contracted disk-like structures, which might correspond to distorted vesicle-internalized HDL particles (Fig. 7C ). The differences in the cryo-TEM results between the effects of HDL (Fig. 7) and LDL ( Fig. 6) are consistent with the chromatic and biophysical data discussed above and most likely reflect the distinct sizes and molecular organization of the two particle species, which affect their membrane interactions.
Discussion
Cholesterol trafficking (influx/efflux) following interactions of lipoproteins with specific membrane-localized receptors is considered a crucial effector in the progression of varied coronary diseases and has by far garnered the most scientific, biomedical and pharmaceutical interest. Here we show that non-specific membrane binding of lipoproteins are significantly modulated in lipoproteins affected by oxidative stress. In particular, we demonstrate that modulation of membrane binding of lipoproteins can be exploited as a powerful marker for oxidative stress using recently developed simple chromatic vesicle and cell assays.
The experiments depicted in Figs. 1 and 2 demonstrated that dramatic differences in chromatic responses were induced by lipoproteins isolated from diabetic patients and by lipoproteins oxidized in vitro compared to native lipoproteins. These differences were clearly apparent both in case of LDL, as well as HDL, and indicate that the abnormal lipoproteins exhibited less affinity to membrane bilayers compared to the native particles. The effects were observed in different vesicle compositions (vesicles comprising DMPC and vesicles containing DMPE/DMPG, Fig. 2 ) pointing to the generality of this phenomenon. Importantly, significant differences in membrane interactions were also recorded in the context of the actual plasma membrane, probed through application of the PDA-labeled live cell assay (Fig. 3) .
Application of biophysical characterization techniques corroborated the chromatic assay data and further highlighted the modulation of membrane binding of lipoproteins in situations of oxidative stress. Specifically, FRET analysis (Fig. 4) pointed to less significant bilayer disruption by diabetic or oxidized lipoproteins compared to physiologically normal particles. Fluorescence quenching experiments (Fig. 5) suggest that diabetes or lipoprotein oxidation reduced binding of LDL or HDL at the bilayer/water interface. Electron microscopy images (Fig. 6 ) underscored the dramatic structural effects of lipoproteins upon vesicle bilayers and the distinctly different effects induced by normal vs. disease-extracted particles.
Overall, this investigation suggests that disease conditions, particularly lipid oxidation, have insidious effects upon membrane interactions of lipoproteins. In particular, this work suggests that membrane-lipoprotein interactions, exposed through application of the newly developed chromatic vesicle and cell assays, might constitute a novel marker for lipoprotein abnormalities. This work points to the potential use of the biomimetic chromatic assays as platforms for rapid detection of oxidative stress-related disease and for screening the effectiveness of therapeutic treatments. In particular, we foresee the development of rapid screening tests, based upon the chromatic vesicle assay, which would either utilize isolated lipoprotein specimens or even complete sera, for detecting adverse oxidative stress conditions.
